CELL INTELLIGENCE · 肿瘤细胞治疗研究

AI 驱动的生物治疗：输血医学与生物治疗交叉领域的人工智能与信息学

AI-powered biotherapies: Artificial intelligence and informatics at the intersection of transfusion medicine and biotherapies.

AI与信息学正被定位为开启精准、数据驱动生物治疗新时代的力量。

用于 CAR-T 细胞快速床旁/体内编程的可注射生物指令性微泡沫

Injectable bioinstructive microfoam for rapid bedside/in vivo programming of CAR-T cells.

促进髓系细胞活化的 CAR-T 细胞因素鉴定

Characterization of CAR-T cell factors that contribute to myeloid cell activation.

实现细胞和基因疗法的公平可及：重新思考共付费用

Toward equitable access to cell and gene therapies: rethinking co-payments.

CAR-T 细胞疗法中的 TCR：用进废退？

The TCR in CAR T cell therapy: use it or lose it?

面向新兴过继性细胞治疗的基于 PCR 的细胞动力学与生物分布分析展望

Perspectives on PCR-Based Cellular Kinetics and Biodistribution Analysis for Emerging Adoptive Cell Therapies.

CAR-T 细胞治疗在儿童、青少年和年轻成人癌症患者中的关键作用

The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancer.

基因和细胞疗法的免疫原性

Immunogenicity of Gene and Cell Therapies.

CRISPR/Cas9 技术用于修饰 CAR-T 细胞治疗血液系统恶性肿瘤中的免疫检查点

CRISPR/Cas9 Technology for Modifying Immune Checkpoint in CAR-T Cell Therapy for Hematopoietic Malignancies.

1 型神经纤维瘤病：遗传机制与治疗创新进展

Neurofibromatosis Type 1: Genetic Mechanisms and Advances in Therapeutic Innovation.